Health Investment Returns: Harnessing Health as...

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recen...
Interchangeable Biosimilar Approval: FDA Greenlights Poherdy as First to Perjeta
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications
Biosimilars Market Trends 2025: Understanding Erosion and Growth
Transforming Cancer Treatment: Implications of Subcutaneous Pembrolizumab App...
NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Su...
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflamma...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing